Effect of Benazepril Treatment in Dogs with Naturally Occurring Chronic Renal Insufficiency
WSAVA 2002 Congress
Jean-Pierre Cotard, DVM, PhD, Diplomate ECVIM-CA
Professeur, Ecole Nationale Vétérinaire de Lyon
France

Benazepril has been shown to have beneficial effects in chronic renal insufficiency (CRI) in man; prolonging survival time and reducing urinary loss of protein (1). We tested the efficacy of benazepril in dogs with CRI. A total of 41 dogs with CRI were randomised to receive benazepril at a dose of 0.25-0.5 mg/kg or matched placebo once daily in a double-blinded clinical trial. Inclusion criteria were CRI of renal origin with plasma creatinine > 142 µmol/l and urine specific gravity < 1.020. The two groups were matched at baseline.

During the trial, benazepril-treated dogs had lower protein in the urine, higher scores for appetite and general clinical condition, and lower loss of body weight as compared to the placebo-group. Differences reached statistical significance (p < 0.05) for urine protein and appetite. The mean survival time in the benazepril group was longer (290 days) than in the placebo group (236 days), although differences did not reach statistical significance (p=0.26).

These interim results suggest, that as in man, benazepril may have beneficial effects in dogs with chronic renal insufficiency.

Reference

1.  Maschio et al. N Eng J Med 1996; 334: 939-945

Speaker Information
(click the speaker's name to view other papers and abstracts submitted by this speaker)

Jean-Pierre Cotard, DVM, PhD, Diplomate ECVIM-CA
Professeur, Ecole Nationale Vétérinaire de Lyon
France


MAIN : : Benazepril: Renal Insufficiency
Powered By VIN

Friendly Reminder to Our Colleagues: Use of VIN content is limited to personal reference by VIN members. No portion of any VIN content may be copied or distributed without the expressed written permission of VIN.

Clinicians are reminded that you are ultimately responsible for the care of your patients. Any content that concerns treatment of your cases should be deemed recommendations by colleagues for you to consider in your case management decisions. Dosages should be confirmed prior to dispensing medications unfamiliar to you. To better understand the origins and logic behind these policies, and to discuss them with your colleagues, click here.

Images posted by VIN community members and displayed via VIN should not be considered of diagnostic quality and the ultimate interpretation of the images lies with the attending clinician. Suggestions, discussions and interpretation related to posted images are only that -- suggestions and recommendations which may be based upon less than diagnostic quality information.

CONTACT US

777 W. Covell Blvd., Davis, CA 95616

vingram@vin.com

PHONE

  • Toll Free: 800-700-4636
  • From UK: 01-45-222-6154
  • From anywhere: (1)-530-756-4881
  • From Australia: 02-6145-2357
SAID=27